Insulin Signaling Is Preserved in Skeletal Muscle During Early Diabetic Ketoacidosis
The Journal of Clinical Endocrinology & Metabolism · 2023
DOI: 10.1210/clinem/dgad464 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2023. Verfasst von Frederikke A Fisker und 8 weiteren Autor:innen. Beteiligte Einrichtung: Steno Diabetes Center Aarhus, Aarhus University Hospital, 8200 Aarhus N, Denmark. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Diabetic Ketoacidosis, Insulin Resistance. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Steno Diabetes Center Aarhus, Novo Nordisk Foundation.
Abstract (Originalsprache)
Background and aims During diabetic ketoacidosis (DKA), muscle tissue develops a profound insulin resistance that complicates reversal of this potentially lethal condition. We have investigated mediators of insulin action in human skeletal muscle during total insulin withdrawal in patients with type 1 diabetes, under the hypothesis that initial phases of DKA are associated with impaired postreceptor signaling. Materials and methods Muscle biopsies were obtained during a randomized, controlled, crossover trial involving 9 patients with type 1 diabetes. The subjects were investigated during a high-dose insulin clamp preceded by either: (1) insulin-controlled euglycemia (control) or (2) total insulin withdrawal for 14 hours. Insulin action in skeletal muscle and whole-body substrate metabolism were investigated using western blot analysis and indirect calorimetry respectively.
Results
During insulin withdrawal, insulin-stimulated dephosphorylation of glycogen synthase decreased by ∼30% (P < .05) compared with the control situation. This was associated with a decrease in glucose oxidation by ∼30% (P < .05). Despite alterations in glucose metabolism, insulin transduction to glucose transport and protein synthesis (Akt, AS160, mammalian target of rapamycin, and eukaryotic translation initiation factor 4E binding protein) was intact, and glucose transporter (GLUT4) and mitochondrial proteins (succinate dehydrogenase complex, subunit A and prohibitin 1) protein expression were unaffected by the intervention.
Conclusion
DKA impairs insulin-stimulated activation of glycogen synthase, whereas insulin signal transduction to glucose transport and protein synthesis remains intact. Reversal of insulin resistance during treatment of DKA should target postreceptor mediators of glucose uptake. Clinical Trial Registration number NCT02077348.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Steno Diabetes Center Aarhus, Aarhus University Hospital, 8200 Aarhus N, Denmark.
- Department of Endocrinology and Internal Medicine, Aarhus University Hospital, 8200 Aarhus N, Denmark.
- Department of Nuclear Medicine, Aarhus University Hospital, 8200 Aarhus N, Denmark.
- Department of Biomedicine, Aarhus University, 8000 Aarhus C, Denmark.
ORCID-Profile: Frederikke A Fisker, Niels Møller, Niels Jessen
Förderung
- Steno Diabetes Center Aarhus
- Novo Nordisk Foundation
Zitieren
APA
Fisker, F. A., Voss, T. S., Svart, M. V., Kampmann, U., Vendelbo, M. H., Bengtsen, M. B., Lauritzen, E. S., Møller, N., & Jessen, N. (2023). Insulin Signaling Is Preserved in Skeletal Muscle During Early Diabetic Ketoacidosis. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad464
Vancouver
Fisker FA, Voss TS, Svart MV, Kampmann U, Vendelbo MH, Bengtsen MB, et al. Insulin Signaling Is Preserved in Skeletal Muscle During Early Diabetic Ketoacidosis. The Journal of Clinical Endocrinology & Metabolism. 2023. doi:10.1210/clinem/dgad464
BibTeX
@article{Fisker2023,
author = {Fisker, Frederikke A and Voss, Thomas S and Svart, Mads V and Kampmann, Ulla and Vendelbo, Mikkel H and Bengtsen, Mads B and Lauritzen, Esben S and Møller, Niels and Jessen, Niels},
title = {Insulin Signaling Is Preserved in Skeletal Muscle During Early Diabetic Ketoacidosis},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2023},
doi = {10.1210/clinem/dgad464}
}
EUVIMED